| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 07/12/2000 | CN1054294C Prepn. of Chinese herb medicine for constricting woman vagina |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087362 Treating erectile dysfunction in a human patients by administering prior to sexual activity |
| 07/11/2000 | US6087173 Antisense modulation of X-linked inhibitor of apoptosis expression |
| 07/11/2000 | US6086909 Device and method for treatment of dysmenorrhea |
| 07/11/2000 | US6086884 Composition for treating impotence in men containing dried roe and yohimbine |
| 07/11/2000 | CA2188385C Dosage forms and method for ameliorating male erectile dysfunction |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | WO2000039128A1 5ht1 antagonists for antidepressant therapy |
| 07/06/2000 | WO2000039123A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039122A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039120A2 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | WO2000039099A1 Benzimidazole derivatives |
| 07/06/2000 | WO2000039095A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039090A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039083A2 Pyrazole compounds and uses thereof |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038712A2 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 07/06/2000 | WO2000038704A1 Use of peptide |
| 07/06/2000 | WO2000038691A1 Triphasic oral contraceptive |
| 07/06/2000 | WO2000038666A2 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038659A1 Transdermal drug delivery system |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000018429A3 Vaccine based on attenuated $i(haemophilus somnus) |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | WO1999063115A9 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 07/06/2000 | WO1999053040A3 Human nucleic acid sequences from ovarian tumour tissue |
| 07/06/2000 | CA2363999A1 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | CA2362492A1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356475A1 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2355254A1 Use of peptide |
| 07/06/2000 | CA2354053A1 A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/05/2000 | EP1016410A1 Glycosaminoglycans for the treatment for pre-eclampsia and related diseases |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015023A1 Use or a secretion vector for fertility control by oral vaccination |
| 07/05/2000 | EP1015010A1 Prevention of pregnancy miscarriages |
| 07/05/2000 | EP1014982A1 Troglitazone compounds for treating climacteric |
| 07/05/2000 | EP1014971A1 Treatment for premenstrual dysphoric disorder |
| 07/05/2000 | EP1014963A1 Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia |
| 07/05/2000 | CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis |
| 07/05/2000 | CN1258673A New imidazole derivate and its producing process |
| 07/05/2000 | CN1258535A Kidney invigorating and blood circulation activating Chinese medicine preparation and its preparation process and application |
| 07/05/2000 | CN1054054C Application of rhizoma zingiberis in preparation of fetal conversion plaster |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6083956 Optically pure androgen mediator |
| 07/04/2000 | US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083916 Pharmaceutical product for application to uterus mucosa |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract |
| 07/04/2000 | CA2116565C Low speed model following velocity command system for rotary wing aircraft |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 07/04/2000 | CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 06/30/2000 | CA2293890A1 A novel treatment for pre-eclampsia and related diseases |
| 06/29/2000 | WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037109A2 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000037100A2 Compositions and methods for reducing or preventing fertilization in fish and birds |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037084A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037061A2 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION |
| 06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
| 06/29/2000 | WO2000000594A3 Human transferases |
| 06/29/2000 | WO1999066909A3 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues |